Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
CRE26-060: Triple Threat: Co-occurrence of Hypogammaglobulinemia, SMARCA4-Deficient Lung Cancer, and Stage IV Mantle Cell Lymphoma With Sustained Immunotherapy Response.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026
CRE26-060: Triple Threat: Co-occurrence of Hypogammaglobulinemia, SMARCA4-Deficient Lung Cancer, and Stage IV Mantle Cell Lymphoma With Sustained Immunotherapy Response.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Showing 1-2 of 2
Last Updated: 09/26/2026